Mastering Competitiveness in Pharma | By Trilations

Jeremy Padbury, Global Commercial Strategy Director Oncology at GSK , joins Mastering Competitiveness to talk about execution, and why it matters more than ever. He shares how clear goals , aligned KPIs , and true global-to-local collaboration can help teams execute with confidence . The conversation dives into why competitiveness is a true team sport and how cross-functional collaboration enables...

Annie Curti, Director and Launch Excellence Lead at Novartis, brings over 15 years of experience in life sciences consulting and biopharma leadership. In this episode of Mastering Competitiveness, she shares what it takes to launch successfully in today’s complex pharma environment: from aligning cross-functional teams to defining the right success metrics and keeping patient needs at the center....

Koen Union, Global Head of Market Research & Insights at UCB Biopharma, joins Trilations' CEO Johan Vermeiren and COO Claire Versluys to discuss how pharma insights teams can drive business impact through benchmarking, AI, and global-to-local planning.

How can pharma companies stay competitive in a saturated market? In this episode, Tim Talomie, VP Oncology Global Marketing at Merck , shares insights on building a differentiated commercial strategy and aligning teams for impact. What you'll learn: How to define value beyond clinical efficacy The importance of understanding key stakeholders: HCPs, payers, regulators, and patients Why cross-functi...

How can medical affairs be a key driver of competitiveness rather than just a support function? In this first episode, Paul Burton, Chief Medical Officer at Amgen , discusses the evolving role of medical strategy in shaping corporate competitiveness. What you'll learn: How medical affairs can drive competitive success Why benchmarking in medical strategy is complex —and how to do it right The grow...